KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
$1.04
+0.0200 (+1.96%)
At Close: Apr 26, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.90 $2.68 Friday, 26th Apr 2024 FGEN stock ended at $1.04. This is 1.96% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 8.67% from a day low at $0.98 to a day high of $1.06.
90 days $0.88 $2.93
52 weeks $0.335 $19.47

Historical FibroGen prices

Date Open High Low Close Volume
Apr 28, 2023 $16.59 $17.38 $16.56 $17.12 940 880
Apr 27, 2023 $16.35 $16.88 $16.14 $16.71 909 411
Apr 26, 2023 $16.31 $16.68 $15.89 $16.30 762 155
Apr 25, 2023 $16.84 $16.98 $16.21 $16.39 1 693 319
Apr 24, 2023 $20.28 $20.28 $16.40 $16.89 2 450 181
Apr 21, 2023 $20.12 $20.44 $19.82 $20.40 748 420
Apr 20, 2023 $20.16 $20.52 $19.79 $19.98 778 695
Apr 19, 2023 $20.12 $20.73 $19.88 $20.40 591 092
Apr 18, 2023 $20.70 $20.90 $20.41 $20.48 694 120
Apr 17, 2023 $19.70 $20.71 $19.70 $20.59 598 000
Apr 14, 2023 $19.61 $19.68 $19.30 $19.63 507 915
Apr 13, 2023 $18.83 $20.00 $18.74 $19.68 843 036
Apr 12, 2023 $18.65 $18.98 $18.55 $18.72 474 252
Apr 11, 2023 $19.17 $19.33 $18.45 $18.51 728 375
Apr 10, 2023 $19.52 $19.97 $18.80 $19.19 648 659
Apr 06, 2023 $18.92 $19.62 $18.80 $19.59 845 165
Apr 05, 2023 $18.70 $19.08 $18.52 $18.85 942 079
Apr 04, 2023 $18.96 $19.01 $18.28 $18.79 662 328
Apr 03, 2023 $18.76 $19.37 $18.66 $19.01 711 470
Mar 31, 2023 $18.83 $19.07 $18.45 $18.66 910 763
Mar 30, 2023 $19.51 $19.54 $18.57 $18.73 775 070
Mar 29, 2023 $18.88 $19.46 $18.83 $19.46 984 129
Mar 28, 2023 $18.64 $18.96 $18.64 $18.81 471 636
Mar 27, 2023 $18.17 $18.71 $18.17 $18.71 500 225
Mar 24, 2023 $18.43 $18.47 $18.04 $18.15 680 624
Click to get the best stock tips daily for free!

About FibroGen

FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China ... FGEN Profile

Golden Star

Ticker Date Change Price
DHT Apr 24 2.04% $11.28
MLI Apr 19 9.66% $52.28
LPLA Apr 19 1.42% $262.59
DOOR Apr 18 0.167% $131.39
LNG Apr 17 1.49% $156.81
FCN Apr 16 1.80% $207.62
ELV Apr 16 5.97% $506.97
AKR Apr 05 4.78% $16.53
ITCI Apr 05 7.04% $68.44
VSTS Apr 04 0.425% $18.82
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT